Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>HSBC Research Warns US Tariffs May Dent A-Shr Earnings, Remains Bullish on Xiaomi, CR Beer, Tingyi, Hansoh Pharma
Recommend 31 Positive 60 Negative 26 |
||||
|
||||
|
HSBC Global Research released a report forecasting that escalating tariffs will reduce CSI 300 earnings by 5-7%, vs an earlier estimate of 3-4%. However, the situation remained fluid and could change swiftly. Reflecting recent developments, the broker lowered its targets for the Shanghai Composite Index, CSI 300, and Shenzhen Component Index to 3,600, 4,300, and 11,500, respectively, implying upside of 11.2%, 14.7%, and 16.5%. The broker upgraded healthcare to Overweight and industrials to Neutral, while remaining optimistic on consumer goods and information technology. Despite current volatility, the broker maintained that China’s stock market will demonstrate long-term resilience, backed by policy measures and broad shift in the China narrative among global investors. The report highlighted a Buy recommendation for select stocks, including XIAOMI-W (01810.HK), CHINA RES BEER (00291.HK), TINGYI (00322.HK), and HANSOH PHARMA (03692.HK). AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
